Showing results (71-80 of 113) with videos related to
Sort By:
Pageof 12
Annals of the Rheumatic Diseases|February 1, 1992
Contribution of inherited factors to rheumatoid arthritisC M Deighton, J Wentzel, G Cavanagh, et al.Physiological Measurement|February 1, 1997
A continuous patient activity monitor: validation and relation to disabilityD J Walker, P S Heslop, C J Plummer, et al.Rheumatology (Oxford, England)|October 3, 2003
Serum MMP-1 and TIMP-1 levels are increased in patients with psoriatic arthritis and their siblingsA Myers, R Lakey, T E Cawston, et al.British Journal of Rheumatology|October 1, 1993
Both inherited HLA-haplotypes are important in the predisposition to rheumatoid arthritisC M Deighton, G Cavanagh, A S Rigby, et al.Arthritis and Rheumatism|January 1, 1987
Linkage studies of HLA and rheumatoid arthritis in multicase familiesD J Walker, J Burn, I D Griffiths, et al.International Journal of Clinical Practice|May 17, 2006
Duloxetine 60 mg once daily in the treatment of milder major depressive disorderD G S Perahia, D K Kajdasz, D J Walker, et al.Annals of the Rheumatic Diseases|November 1, 1992
P blood group phenotype, proteus antibody titres, and rheumatoid arthritisC M Deighton, J Gray, D F Roberts, et al.The Journal of Clinical Psychiatry|March 10, 2001
Weight change and atypical antipsychotic treatment in patients with schizophreniaB Jones, B R Basson, D J Walker, et al.Molecular and Biochemical Parasitology|May 5, 1998
Developmental and tissue-specific expression of 2-methyl branched-chain enoyl CoA reductase isoforms in the parasitic nematode, Ascaris suumE Duran, D J Walker, K R Johnson, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|May 16, 2006
Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trialD G S Perahia, F Wang, C H Mallinckrodt, et al.Pageof 12